Muscle Stimulation Devices Market

Muscle Stimulation Devices Market Outlook for (2023 to 2033)

The muscle stimulation devices market size is projected to be worth USD 720.4 million in 2023. The Industry is projected to reach USD 996.7 million by 2033 and is expected to expand at a CAGR of 3.3% from 2023 to 2033.

Key Market Trends and Highlights

• Increasing emphasis on fitness and sports performance has driven the demand for muscle stimulation devices. Athletes and fitness enthusiasts use these devices to enhance muscle strength, endurance, and recovery, aiding in better workout outcomes.
• Muscle stimulation devices are integral to physical therapy and pain management. They facilitate muscle re-education and alleviate pain, making them essential tools for rehabilitation after injuries or surgeries.
• Advancements in technology have led to the development of compact, portable, and wearable muscle stimulation devices. These user-friendly, wireless options offer convenience and flexibility, expanding the market's reach.
• Muscle stimulation devices are increasingly integrating with smartphone apps and wearable tech, allowing users to monitor and customize their sessions. This connectivity enhances user experience and data-driven fitness management.

Attributes	Key Insights
Muscle Stimulation Devices Market Estimated Size in 2023	USD 720.4 million
Projected Market Value in 2033	USD 996.7 million
Value-based CAGR from 2023 to 2033	3.3%

2018 to 2022 Historical Analysis vs. 2023 to 2033 Market Forecast Projections

The scope for muscle stimulation devices rose at a 3.8% CAGR between 2018 and 2022. The global market for muscle stimulation devices is anticipated to develop at a moderate CAGR of 3.3% over the forecast period from 2023 to 2033.

Attributes	Details
Market Value in 2018	USD 610.09 million
Market Value in 2022	USD 694.7 million
CAGR from 2018 to 2022	3.8%

The muscle stimulation devices market experienced steady growth during the historical period due to increasing awareness of fitness and rehabilitation benefits. Advancements in portable and wearable muscle stimulation devices became prominent, making them user-friendly and appealing to a broad consumer base.

The industry is predicted to be driven by the growing popularity of combined therapy using IFT physiotherapy and muscle stimulation devices in future years. These combination therapies are going to be utilized for managing lower back and joint pain.

According to the NCBI, the incidence of knee osteoarthritis in adults aged 20 and up was 203 per 10,000 in 2020. The disease is anticipated to become highly widespread in young people owing to excess weight, heredity, and athletics. This aspect boosts the consumption of combination therapy, especially muscle stimulation devices, during the period of projection.

Muscle Stimulation Devices Market Shaping Factors

• Growing health consciousness and a surge in fitness and sports participation have fueled demand for muscle stimulation devices. These devices offer a supplementary means to enhance muscle strength, endurance, and recovery, appealing to athletes and fitness enthusiasts seeking improved performance.
• An aging global population has led to increased rehabilitation and physical therapy requirements. These tools are essential for muscle re-education, pain management, and post-surgery recovery, making them vital in addressing the healthcare needs of an aging demographic.
• Ongoing technological advancements have resulted in user-friendly, portable, and wearable muscle stimulation devices. These innovations are expanding the market's reach, making it accessible to a broad consumer base.
• Muscle stimulation devices are increasingly integrated into medical practices for managing conditions such as muscle atrophy, neurological disorders, and chronic pain. This medical adoption is boosting the market growth.
• Regulatory bodies have recognized the importance of ensuring the safety and efficacy of muscle stimulation devices. The establishment of clear guidelines and standards is providing confidence to both consumers and healthcare professionals, driving market growth.

Muscle Stimulation Devices Market Restraining Factors

• Stringent regulations and varying certification requirements in different regions can hinder market growth. Complying with these regulations can be time-consuming and costly for manufacturers, potentially limiting product availability.
• There is some evidence supporting the benefits of muscle stimulation devices, but further research is needed to establish their long-term efficacy and safety conclusively. Skepticism among healthcare professionals and consumers regarding the effectiveness of these devices can slow adoption.
• Muscle stimulation devices face competition from other fitness and rehabilitation technologies, including traditional exercise equipment, physical therapy, and pharmaceutical treatments. Convincing consumers and healthcare providers of the unique advantages of muscle stimulation over these alternatives can be challenging.

Country-wise Insights

The below table showcases revenues in terms of the top 4 leading countries, spearheaded by the United States and China. These two countries are expected to lead the market through 2033.

Forecast market share in 2023

The United States	82.4%
China	33%
The United Kingdom	18.6%
Japan	18%

Growing Number of Senior Citizens to Boost the Market in the United States

The United States is expected to develop significantly during the evaluation period, fueled by a rising incidence of chronic diseases. The muscle stimulation devices market in North America around 51.0% of the total in 2022. The market in the United States is poised to hold a market share of 82.4% of North America.

According to the Centers for Disease Control and Prevention (CDC), around 20.4% of individuals in the United States suffered from chronic pain in 2019. People between the ages of 45 and 64, as well as those 65 and older, experienced more pain. This demonstrates that the country's burgeoning geriatric population is projected to promote market expansion throughout the coming years.

Substantial federal investments in medical device invention and advancement, as well as the early release of innovative muscle stimulators, are supporting the expansion of the region. Customers' high spending power, along with high utilization of modern technologies and novel medical gadgets, are likely to drive the development of the United States.

Emergence of Medtech Companies to Play Key Role in the United Kingdom Market

The emergence of multiple prominent medtech and healthcare equipment businesses is expected to make the United Kingdom one of the significant markets for stimulation devices in the years to come.

According to Future Market Insights, the Western Europe muscle stimulation devices market accounts for around 23.2% of the total in 2023. The market in the United Kingdom is estimated to hold a market share of 18.6% of Europe.

Sky Medical, a biomedical products business based in the United Kingdom, for example, got FDA certification for its portable electrical muscle stimulator in December 2021. It is currently employed to manage specific symptoms of persistently clogged vessels, including blood pooling in the legs and varicose veins.

The increasing emphasis of multiple businesses on expediting product authorization for advertising and sales objectives is anticipated to accelerate growth in this country. Also, the government's efforts in the establishment of the country's medical facilities are expected to boost the rapid implementation of these devices in residential care setups.

Utilization of Smart Gadgets to Expand the Market in China

China is expected to demonstrate an impressive rate of growth during the period of evaluation owing to the rising use of smart gadgets for health maintenance.

According to FMI, the Asia Pacific Excluding Japan (APEJ) muscle stimulation devices market accounted for 10.9% of the total in 2022. The market in China is estimated to hold a market revenue of 18.6% of Asia Pacific.

Increased acceptance of pain management medicines and rising health and fitness consciousness are expected to drive innovation in this country. The introduction of technologically improved muscle stimulators is predicted to increase the popularity of these devices in China.

The rising demand for pain management methods in hospitals is expected to boost the market in China in the approaching years.

Robust Regulatory Framework for Medical Equipment to Propel the Market in Japan

The market in Japan is expected to hold a market share of 18% of Asia Pacific. The aging population of Japan is significantly contributing to the demand for muscle stimulation devices, particularly in the context of rehabilitation and physical therapy.

Fitness and sports enthusiasts have also embraced these devices as complementary tools to enhance performance and expedite post-workout recovery. Manufacturers in Japan are known for their technological innovation, resulting in advanced and user-friendly muscle stimulation devices that often incorporate smart features.

The robust regulatory framework of Japan for medical devices ensures the safety and efficacy of products, making compliance a crucial factor for market entry. The market is competitive, with domestic and international manufacturers striving to differentiate their offerings through innovation and clinical evidence.

Collaborations with healthcare providers, educational efforts to inform consumers, and the rising interest in holistic health and wellness have further fueled market growth. The muscle stimulation devices market in Japan continues to evolve to meet the diverse needs of consumers, encompassing the healthcare, fitness, and sports sectors.

Category-wise Insights

The below table highlights how transcutaneous electric nerve stimulator (TENS) led the market in terms of product type, accounting for a market share of 71.40% in 2022.

The pain management segment is likely to spearhead sales based on application and witnessed a market share of 52% in 2022.

Category	Market Share (2022)
Transcutaneous Electric Nerve Stimulator (TENS)	71.40%
Pain Management	52%

Transcutaneous Electric Nerve Stimulators to Dominate the Market

Transcutaneous electric nerve stimulator (TENS) demand is expected to rise notably in the forthcoming years due to its growing prevalence in the management of limb pain.

The rising frequency of arthritis and the rise in sports-related injuries are two primary factors driving market expansion. According to the Centers for Disease Control and Prevention (CDC), about 58.5 million people in the United States were identified with arthritis from 2016 to 2018. This figure is expected to rise to 78.4 million by 2040. The growing incidence of arthritis is likely to fuel development in the projected time span.

Rising Incidence of Chronic Pain Drives the Segment's Expansion

Based on application, the pain management segment is expected to command the notable percentage of the global market by 2033. This increase is due to the growing incidence of chronic pain among individuals, which would increase demand for sophisticated technologies and wearables.

The swift advancement of cutting-edge muscle stimulation gadgets for pain management, as well as their widespread use by physiotherapists in managing persistent pain, is projected to promote growth. For instance,

• CyMedica Orthopaedics received FDA approval in June 2021 for their non-invasive approach called Intellihab for the medical care of knee osteoarthritis pain. It is a virtual wellness ecosystem that can improve movement while lowering pain dramatically. The pain management segment is assumed to hold around 52% of the global market's share in 2023.

Competitive Landscape

A significant number of businesses are at present concentrating on releasing cutting-edge solutions to meet the high unfulfilled medical demands in the global muscle stimulation devices market. Several other main businesses intend to expand their geographical reach by establishing additional stores around the world.

• Shenzhen Konmed Technology Co., Ltd. acquired FDA 510(k) premarket authorization for their Biofeedback Nerve and Muscle Stimulator equipment in July 2022. The device is designed to offer electrical stimulation and neuromuscular re-education. It helps to strengthen weak pelvic floor muscles in women suffering from stress, urge, or mixed urine urinary tract problems, as well as to preserve urinary continence in women.
• Cionic Neural Sleeve received FDA authorization in March 2022 for functional electrical stimulation to aid with locomotion for people with foot drop and leg fatigue.

Report Scope

Attribute	Details
Estimated Market Size in 2023	USD 720.4 million
Projected Market Valuation in 2033	USD 996.7 million
Value-based CAGR 2023 to 2033	3.3%
Forecast Period	2023 to 2033
Historical Data Available for	2018 to 2022
Market Analysis	Value in USD million
Key Regions Covered	North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East & Africa
Key Market Segments Covered	Product Type, Application, End User, Region
Key Countries Profiled	The United States, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Spain, Italy, Russia, Poland, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC countries, South Africa, Israel
Key Companies Profiled	DJO Global Inc.; Zynex Inc.; Neurometrix Inc.; R.S. Medical Inc.; Omron Corporation; Beurer; EMS Physio Ltd; Enovis; Abbott; BTL Corporate

Segmentation Analysis of the Muscle Stimulation Devices Market

By Product Type:

• Neuromuscular Electric Stimulator (NMES)
• Transcutaneous Electric Nerve Stimulator (TENS)
• Interferential (If)
• Burst Mode Alternating Current

By Application:

• Pain Management
• Neurological & Movement Disorder Management
• Musculoskeletal Disorder Management

By End-user:

• Hospitals
• Physiotherapy Clinics
• Sports Clinics
• Home Care Settings

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• South Asia & Pacific
• East Asia
• The Middle East & Africa

Frequently Asked Questions

What is the Expected Worth of the Muscle Stimulation Devices Market in 2023?

The muscle stimulation devices market is expected to reach USD 720.4 million in 2023.

What is the Projected CAGR for the Muscle Stimulation Devices Market until 2033?

The market for muscle stimulation devices is set to expand by a CAGR of 3.3% by 2033.

How much Valuation is Projected for the Muscle Stimulation Devices Market in 2033?

The muscle stimulation devices industry is forecast to reach USD 996.7 million by 2033.

Which Country is likely to be at the Pinnacle of the Muscle Stimulation Devices market?

The United States is likely to be the top-performing market, accounting for a market share of 82.4% of North America in 2023.

Which is the Leading Product Type in the Muscle Stimulation Devices domain?

Transcutaneous electric nerve stimulator (TENS) is the leading product type in the muscle stimulation devices market.